TL;DR
This paper tackles the challenge of automatically determining the relationship (entailment or contradiction) between clinical trial statements and their supporting evidence. They propose a two-level system that first retrieves relevant sentences from clinical trial reports and then classifies the inference relation, achieving competitive results by enhancing the process with contextual data augmentation.
What Problem Does This Paper Address?
The ever-growing volume of clinical trial reports makes it difficult for healthcare professionals to stay updated on the latest findings. This paper addresses SemEval 2023 Task 7, which aims to automate the extraction and analysis of data from these reports. Specifically, the task involves two sub-problems:
- Textual Entailment: Determining if a statement about a clinical trial is entailed or contradicted by the trial's text.
- Evidence Retrieval: Identifying the specific sentences within the trial text that support this inference.
The core challenge lies in accurately linking a statement to the correct evidence within complex, often lengthy, clinical trial documents and then making a precise inference about their relationship. Existing methods often struggle with the nuances of clinical language and the need for precise contextual understanding.
Methods
The authors propose a two-level system that reverses the typical order of the subtasks.
- Level 1: Evidence Retrieval (Subtask 2)
- They reframe this as a Question-Answering Natural Language Inference (QNLI) task. The clinical trial statement acts as the "question," and each line of the relevant clinical trial section is treated as a potential "answer."
- A BERT-based classifier is trained to identify which lines from the clinical trial text are relevant to the statement.
- Contextual Data Augmentation: To improve relevance identification, they augment the premise sentences by prepending information such as the trial type (primary/secondary), the parent subsection (e.g., "Inclusion Criteria"), and cohort information. This helps the model understand the context of each piece of evidence.
- Level 2: Inference Classification (Subtask 1)
- The relevant sentences identified in Level 1 are then used, along with the original statement, as input for a second BERT-based classifier.
- This classifier determines the inference relation (entailment or contradiction) between the statement and the retrieved evidence.
- Classifier Fine-Tuning: They experimented with three fine-tuning approaches:
- Standard: Using the entire statement and as much of the concatenated evidence as possible.
- Single Sentence: Creating a separate pair for each evidence sentence and the statement.
- Single Sentence + Augmentation: Similar to the "Single Sentence" approach but with the contextual data augmentation applied to each premise sentence.
Datasets
The primary dataset used is from SemEval 2023 Task 7: Multi-evidence Natural Language Inference for Clinical Trial Data. This dataset consists of breast cancer clinical trial reports, statements, inference relations, and supporting sentences annotated by domain experts. The dataset is split into train, development, and test sets.
Key Insights and Ideas
- Reversing the Task Order: Treating evidence retrieval as a precursor to inference classification proved effective, allowing the system to focus on the most pertinent information.
- Contextual Data Augmentation is Key: Prepending trial and subsection information to premise sentences significantly improved the performance of both subtasks, highlighting the importance of rich context for clinical text understanding.
- Domain-Specific Models Matter: Using BERT-based models pre-trained on biomedical and clinical data (like BioM-BERT and BioBERT) yielded better results than general-purpose models.
- Quantitative Reasoning is a Major Hurdle: The paper identifies quantitative reasoning as a significant challenge, where models struggle to accurately classify statements that require numerical comparisons or calculations.
Key Results
- Subtask 2 (Evidence Retrieval): The system achieved an F1 score of 82.7% on the test set, ranking fifth in the competition. Contextual data augmentation improved the F1 score by 3.7% for this subtask.
- Subtask 1 (Inference Classification): The system achieved an F1 score of 64.4% on the test set. Contextual data augmentation led to a substantial improvement of 7.6% for this subtask.
- The best-performing model for subtask 2 was based on BioM-BERT.
- For subtask 1, BioM-BERT Large also showed strong performance, especially when using the "Single sentence + augmentation" approach.
Limitations and Future Work
- Reliance on Dataset Structure: The effectiveness of the contextual data augmentation relies heavily on the well-structured nature of the clinical trial reports. Variations in structure could pose challenges.
- Input Length Limitations: BERT-based models have fixed input length limits (e.g., 512 tokens), which can lead to truncation of longer premise sections, potentially losing crucial context. Clinical Longformer, with its larger input capacity, showed some advantages in specific scenarios.
- Quantitative Reasoning: The paper explicitly states that handling quantitative reasoning remains a significant challenge. Future work should focus on developing methods to better extract and process quantitative information from clinical texts.
- Scaling to Longer Texts: While the proposed methods show promise, scaling them to even longer clinical documents and more complex inference scenarios is an area for further exploration.
Summary updated